Common diabetes drug could prevent hemorrhage and fatal blood loss

A new study, published today in the British Journal of Pharmacology, by scientists from Royal Holloway, University of London, St George's, University of London and University of Surrey have identified that a drug related to commonly used diabetes treatments provides protection against terminal blood loss.

It is important to stop the blood loss in an accident until the patients arrive...
It is important to stop the blood loss in an accident until the patients arrive at the hospital. A diabetic agent could help.

Massive blood loss often leads to death, and when blood transfusions are unavailable, drugs are currently being tested that can keep people alive until they get to hospital. Understanding how these drugs work, and finding improved drugs, has up to now proved difficult. But the latest research has uncovered the way the diabetes drug can protect against changes occurring at a cellular level during severe blood loss.

Prof. Robin Williams from the School of Biological Sciences at Royal Holloway explains: "Our study provides strong evidence that compounds related to the treatment of diabetes could be used to protect against death induced by massive blood loss and save many lives.

"We began looking at a widely used treatment for epilepsy and bipolar disorder, valproic acid, that has been shown to protect against terminal blood loss. By identifying how valproic acid works, we have been able to find more potent drugs, including compounds of the thiazolidinedione class of drugs that are used as hypoglycaemic treatments for diabetes."

Approximately 40% of early human deaths due to trauma are caused by haemorrhage and resulting shock and 62% of these deaths occur in the first four hours. Therefore timely management of this pathological state is central to saving lives. The study has focussed on identifying treatments that are likely to protect against this shock, over the critical four hours post incident.

Source: Royal Holloway, University of London


Read all latest stories

Related articles


Danish study: Depression contributes to preventable hospitalizations

Individuals with depression are more than twice as likely to have hospitalizations that might be preventable with timely outpatient medical care in the community, a new study finds.


Brain bleeds

America's aging population will require more neurosurgeons

Researchers at NYU Langone Medical Center project a national influx of patients who will need immediate treatment.


The fmCh Public Database

Swiss surgical patients can check on and correct their treatment data and thereby facilitate reliable hospital benchmarking. In 1995, surgeons in the Biel, Burgdorf and Zurich Limmattal hospitals…

Related products

Analyticon Biotechnologies AG - Urilyzer 100 Pro


Analyticon Biotechnologies AG - Urilyzer 100 Pro

Analyticon Biotechnologies AG
Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Greiner – VACUETTE FC Mix tube

Blood Glucose

Greiner – VACUETTE FC Mix tube

Greiner Bio-One
Lifotronic - FA-160 Immunofluorescence Analyzer


Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Subscribe to Newsletter